A yearlong investigation revealed that over $6 billion from opioid settlements was distributed across the U.S., with varying degrees of transparency and tracking in expenditures.
States spent or committed about a third of their opioid settlement funds, with the allocation heavily skewed towards addiction treatment and recovery services, leaving significant portions untraceable.
The investigation highlighted that states on average dedicated only a small fraction of the funds for harm reduction and syringe services, raising concerns about their efficacy.
With reports ranging from $11.74 spent on postage to over $51 million for expanding the addiction treatment workforce, the utilization of settlement funds appears disjointed and underreported.
Collection
[
|
...
]